<link rel="stylesheet" href="styles.84630ab4f3c563f3.css"> Skip to main

Federal Register of Legislation annual survey

Have your say on the Federal Register of Legislation. Complete our annual survey and tell us about your experience using the Register.

Designation of Isavuconazonium Sulfate as an orphan drug by JACE Pharma

Administered by
  • Department of Health, Disability and Ageing

This item is authorised by the following title:

Latest version
C2016G0004607 January 2016

Legislation text